Cargando…
Re-Analysis of Modeling a Switch from a 13-Valent to 10-Valent Pneumococcal Conjugate Vaccine in Canada: Leveraging Real-World Experience from Belgium
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6374238/ https://www.ncbi.nlm.nih.gov/pubmed/30460606 http://dx.doi.org/10.1007/s40121-018-0222-1 |
| _version_ | 1783395106093531136 |
|---|---|
| author | Wasserman, Matt D. Sings, Heather L. Wilson, Michele R. Postma, Maarten J. Breton, Marie-Claude McDade, Cheryl Farkouh, Raymond A. |
| author_facet | Wasserman, Matt D. Sings, Heather L. Wilson, Michele R. Postma, Maarten J. Breton, Marie-Claude McDade, Cheryl Farkouh, Raymond A. |
| author_sort | Wasserman, Matt D. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6374238 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Springer Healthcare |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-63742382019-03-04 Re-Analysis of Modeling a Switch from a 13-Valent to 10-Valent Pneumococcal Conjugate Vaccine in Canada: Leveraging Real-World Experience from Belgium Wasserman, Matt D. Sings, Heather L. Wilson, Michele R. Postma, Maarten J. Breton, Marie-Claude McDade, Cheryl Farkouh, Raymond A. Infect Dis Ther Commentary Springer Healthcare 2018-11-20 2019-03 /pmc/articles/PMC6374238/ /pubmed/30460606 http://dx.doi.org/10.1007/s40121-018-0222-1 Text en © The Author(s) 2018 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
| spellingShingle | Commentary Wasserman, Matt D. Sings, Heather L. Wilson, Michele R. Postma, Maarten J. Breton, Marie-Claude McDade, Cheryl Farkouh, Raymond A. Re-Analysis of Modeling a Switch from a 13-Valent to 10-Valent Pneumococcal Conjugate Vaccine in Canada: Leveraging Real-World Experience from Belgium |
| title | Re-Analysis of Modeling a Switch from a 13-Valent to 10-Valent Pneumococcal Conjugate Vaccine in Canada: Leveraging Real-World Experience from Belgium |
| title_full | Re-Analysis of Modeling a Switch from a 13-Valent to 10-Valent Pneumococcal Conjugate Vaccine in Canada: Leveraging Real-World Experience from Belgium |
| title_fullStr | Re-Analysis of Modeling a Switch from a 13-Valent to 10-Valent Pneumococcal Conjugate Vaccine in Canada: Leveraging Real-World Experience from Belgium |
| title_full_unstemmed | Re-Analysis of Modeling a Switch from a 13-Valent to 10-Valent Pneumococcal Conjugate Vaccine in Canada: Leveraging Real-World Experience from Belgium |
| title_short | Re-Analysis of Modeling a Switch from a 13-Valent to 10-Valent Pneumococcal Conjugate Vaccine in Canada: Leveraging Real-World Experience from Belgium |
| title_sort | re-analysis of modeling a switch from a 13-valent to 10-valent pneumococcal conjugate vaccine in canada: leveraging real-world experience from belgium |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6374238/ https://www.ncbi.nlm.nih.gov/pubmed/30460606 http://dx.doi.org/10.1007/s40121-018-0222-1 |
| work_keys_str_mv | AT wassermanmattd reanalysisofmodelingaswitchfroma13valentto10valentpneumococcalconjugatevaccineincanadaleveragingrealworldexperiencefrombelgium AT singsheatherl reanalysisofmodelingaswitchfroma13valentto10valentpneumococcalconjugatevaccineincanadaleveragingrealworldexperiencefrombelgium AT wilsonmicheler reanalysisofmodelingaswitchfroma13valentto10valentpneumococcalconjugatevaccineincanadaleveragingrealworldexperiencefrombelgium AT postmamaartenj reanalysisofmodelingaswitchfroma13valentto10valentpneumococcalconjugatevaccineincanadaleveragingrealworldexperiencefrombelgium AT bretonmarieclaude reanalysisofmodelingaswitchfroma13valentto10valentpneumococcalconjugatevaccineincanadaleveragingrealworldexperiencefrombelgium AT mcdadecheryl reanalysisofmodelingaswitchfroma13valentto10valentpneumococcalconjugatevaccineincanadaleveragingrealworldexperiencefrombelgium AT farkouhraymonda reanalysisofmodelingaswitchfroma13valentto10valentpneumococcalconjugatevaccineincanadaleveragingrealworldexperiencefrombelgium |